-
Ademetionine in Neurological Disorders: Evidence
2026-08-21
The 1994 review by Bottiglieri, Hyland, and Reynolds positioned ademetionine, or S-adenosylmethionine (SAMe), as a biochemical link between one-carbon metabolism, neurotransmitter regulation, and neurological disease. Its main contribution was an integrated interpretation of mechanistic, deficiency-related, and early clinical evidence, while also emphasizing that therapeutic conclusions remained preliminary in several disorders.
-
Chemerin–NTS Signaling Raises Sympathetic Drive
2026-08-20
This 2024 study identifies a chemerin–CMKLR1–NADPH oxidase pathway in the caudal nucleus tractus solitarius that increases sympathetic nerve activity, blood pressure, and heart rate. Pharmacological tests further indicate that the downstream paraventricular nucleus response depends more strongly on NMDA receptors than on AMPA/kainate receptors, refining interpretation of glutamatergic signaling in neurocardiovascular circuits.
-
Tumor-Targeted T Cell Engineering for Cold Tumors
2026-08-20
He et al. develop a TERT promoter-controlled plasmid that co-localizes LIGHT-mediated immune remodeling with membrane-anchored anti-CD3 activity in tumors. The approach improves T-cell recruitment, intratumoral function, and persistence while enhancing checkpoint inhibitor and CAR-T responses across several immune-cold solid-tumor models.
-
TAK1 Inhibition at the Metabolic–Inflammatory Nexus
2026-08-19
A translational perspective on how (5Z)-7-Oxozeaenol enables precise TAK1 interrogation across inflammatory and metabolic-stress biology, with practical guidance for experimental design, validation, and interpretation.
-
Pyridostigmine and Placental Necroptosis in Preeclampsia
2026-08-19
The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves disease-associated outcomes in a reduced uterine perfusion pressure rat model. Pharmacological reversal by α-bungarotoxin links these effects to α7 nicotinic acetylcholine receptor signaling and provides a mechanistic framework for studying non-neuronal cholinergic regulation of placental injury.
-
Measuring Drug Response Beyond Cell Viability
2026-08-18
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability to clarify how cancer drugs combine growth inhibition and cell killing. Its central implication is practical: drug-response studies should measure proliferation and death as related but noninterchangeable outcomes, ideally with attention to their different timing.
-
USP36–Snail1 Control of Ribotoxic Stress in Cancer
2026-08-18
The reference study identifies a noncanonical nucleolar function for Snail1: after ribotoxic stress, JNK-driven USP36 induction stabilizes nucleolar Snail1, supporting ribosome biogenesis and cancer-cell survival. This mechanism helps explain why homoharringtonine is active in leukemia but relatively ineffective against solid tumors, and it provides a rationale for combination strategies that disrupt the JNK–USP36–Snail1 axis.
-
Aclacinomycin A for DNA Damage Workflows
2026-08-17
Aclacinomycin A, also called Aclarubicin, combines dual topoisomerase inhibition with apoptosis and proteasome-related activity for layered cancer-cell assays. This guide translates that pharmacology into practical workflows for DNA damage, nucleolar stress, caspase signaling, and persistent lesion studies while separating validated findings from optimization starting points.
-
V5 Epitope Tag Peptide: Kinetics-Aware Workflows
2026-08-17
The V5 Epitope Tag Peptide supports more than routine protein detection: it can help researchers distinguish epitope accessibility, antibody specificity, and binding kinetics across assays. This guide connects the GKPIPNPLLGLDST peptide with practical Western blotting, immunoprecipitation, and single-molecule imaging decisions.
-
WM-8014: Timing Epigenetic Assays for Causality
2026-08-16
WM-8014 is a potent KAT6A inhibitor for separating immediate acetyltransferase dependence from delayed senescence phenotypes. This guide translates RESTRICT-seq concepts into practical assay design, controls, and interpretation for cancer biology research.
-
A-769662: Mechanism, Assays, and Metabolic Insight
2026-08-15
A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, autophagy, and proteasome-linked phenotypes. This guide connects its pharmacology to modern assay design and explains why AMPK activation should not automatically be interpreted as autophagy induction.
-
Cyanidin Chloride: From Redox Control to Translation
2026-08-14
A translational framework for evaluating Cyanidin Chloride across radical-scavenging, inflammatory, and epithelial barrier models while distinguishing direct aglycone evidence from related glycoside findings.
-
Thioguanine: Mechanism-to-Assay Guide
2026-08-14
Thioguanine and 6-thioguanine connect purine metabolism with experimentally testable antitumor and antiviral phenotypes. This guide explains how to separate HGPRT, DNMT1-related, apoptosis, and viability signals when designing reproducible assays.
-
PID1, Oxysterols, and Antitumor Macrophage Reprogramming
2026-08-13
The reference study identifies PID1 as an immunometabolic regulator that suppresses LDL uptake and limits the generation of antitumor oxysterols in tumor-associated macrophages. Its findings connect PID1 loss to cholesterol accumulation, reactive oxygen species, 5α,6α-epoxycholesterol and 7β-hydroxycholesterol production, inhibition of mTOR–STAT6 signaling, and improved CD8+ T cell-mediated tumor control.
-
Sin3L/Rpd3L HDAC Activation by Inositol Phosphates
2026-08-12
Marcum and Radhakrishnan showed that inositol phosphates stimulate HDAC1/2 activity in the conserved Sin3L/Rpd3L complex through the SAP30 zinc finger, a mechanism functionally analogous to—but structurally distinct from—the SANT-domain mechanism found in other HDAC assemblies. Their biochemical, interaction, and NMR experiments also identified RBBP4 as a constitutive activity-enhancing subunit, separating inducible and baseline regulation within one complex.